- Visibility 229 Views
- Downloads 25 Downloads
- DOI 10.18231/j.ijohd.2020.018
-
CrossMark
- Citation
Adjuvant therapy for oral submucous fibrosis
- Author Details:
-
Mutum Sangeeta Devi *
-
Manju J
-
Rahul Rajpurohit
-
Khumukcham Sophia
-
Binita Sorokhaibam
Introduction
Oral submucous fibrosis (OSMF) is a chronic precancerous condition which is characterized by juxta-epithelial inflammatory reaction and leads to progressive fibrosis of the submucosal tissues of oral cavity.[1] OSMF etiopathogenesis has not been fully understood so far, but areca nut has been reported as main etiological factor. Arecoline and Tanin found in areca nut result in an increased synthesis of collagen and decreased breakdown.[2] Chilies, tobacco, lime, dietary deficiency, abnormal iron metabolism, collagen disorders, bacterial infection, immunological disorders, genetic susceptibility and change in salivary composition are also found as other etiological causes.
Symptoms of OSMF differ with progression of disease. Initial signs are ulcerations of the mucosa, and feeling of burning sensation, Stiffness and blanching of oral mucosa occurs as the disease progress. The most distinctive characteristic of OSMF is palpable fibrous bands in oral mucosa[3], [4] results in marked stiffness and difficulty to open mouth.[5], [6] Other characteristics of the disease include dryness of oral cavity, recurrent ulcer and pigmentation of the oral mucosa, burning sensation, reduced opening of the mouth and protrusion of the tongue. Histopathological review reveals subepithelial fibrosis and chronic inflammation which is followed by hyalinisation and vascular loss, parakeratosis squamous hyperplasia.[7], [8]
The various treatment protocols which have been attempted to improve the signs and symptoms of OSMF include intralesional injections of corticosteroids, placental extracts and hyaluronidase alone or in combination, laser treatment, surgical, IFN-γ, peripheral vasodilators administration, minerals, sugars, lignin, immune milk, turmeric, lycopene and micronutrient supplements. Various physiotherapeutic modalities have also shown favourable results.[9] Natural ayurvedic treatment along with lifestyle change can help to reduce the symptoms of OSMF and thus provide relief to the patient without having to cause side effects.[10] This article provides a review of various adjuvant treatment modalities of OSMF.
Adjuvant Therapies
Curcumin
Curcumin is a plant-isolated polyphenol (Curcuma longa) L.(Zingiberaceae) compound found in Southern Asia.[11] The exact mechanism of action and determination of bioactive materials have been examined for the medicinal properties of turmeric which is curcumin source.[12] It has three properties such as lipid peroxidation inhibition, cellular proliferation screening and inhibition of collagen synthesis.[13] Many studies show effects curcumin in increased mouth opening of patient with OSMF. [14] Studies shows improvement in mouth opening and burning sensation.[15] Curcumin's antioxidant activity was reported in 1975.[16] It acts as an oxygen-free radical scavenger. Curcumin has a powerful inhibitory effect in human keratinocytes and fibroblasts against H2O2-induced damage.[17]
Aloe Vera
Aloe vera works as a wound-healing hormone and serols that is highly anti-inflammatory. Sudarshan et al reported improvement of burning sensation and opening of the mouth compared with antioxidant treatment.[18] Aloe vera contains 75 potentially active constituents which includes vitamins, enzymes, minerals, sugars, lignin, saponins, salicylic acids and amino acids. Vitamins are vitamin A (beta-carotene), C and E which are antioxidants and help to neutralize free radicals. Bradykinase helps decrease inflammation when applied topically to the skin or mucosa. The gel of aloe vera leaves contained polysaccharides which has wound healing, anti-inflammatory, anticancer, immunomodulatory and gastro-protective properties. Properties of aloe vera suggest the possibility of its use in the management of OSMF.[19]
Tulsi
Tulsi increases immunity and enhances metabolism. It is an extract which has been found inhibiting enzymes to reduce inflammation. It is also decreasing depression and exhibits antioxidant properties.[20], [21] It has antioxidant, anti-inflammatory, chemo-preventive, anticarcinogenic and immunomodulatory etc.[10], [22] According to Adit Srivastava et al., the synergistic activity of tulsi has resulted in greater effectiveness and highly effective anti-OSMF therapy. During the first month of testing, it triggered an early, prolonged and substantial decrease during burning sensation, both clinically and statistically. Mouth opening has also changed significantly. In extreme cases, the findings were better representing its greater efficacy.[23]
Sesame oil
Sesame plant (Sesamumindicum/tila) is Pedaliaceae family which was considered a gift of nature to mankind due to its nutritious properties and other beneficial health effects. The seeds are known as "gingelly" or "til". It is a good source of vitamin E with high concentration of polyunsaturated fatty acids and contains antioxidants namely sesamol, sesaminand sesamolin which help in treatment of OSMF.[2]
Spirulina
It is microalgae, found in native of African and American everyday diets. It contains phenolic acid, tocopherols and beta-carotene with antioxidant properties. Spirulina has been used with positive results in treating many oral mucosal lesions.[24] According to Shetty P et al spirulina shows the effective result in treating OSMF pateints.[25] Use of spirulina in the successful management of OSMF is attributed to its antioxidant, anti- inflammatory and immuno-modulating properties.[26] The blue green algae, spirulina is rich in carotenoids and other micronutrients possessing chemo preventive potential. It has been used to test the clinical activity in reversing the oral precancerous lesions like leukoplakia.[27]
Lycopene
Lycopene is bright red carotene with carotenoid pigment found in fruits and vegetables including tomatoes, apricots, papaya, watermelon, carrots and other fruits of yellow colour. Through maintaining essential cellular biomolecules including lipids, lipoproteins, proteins and DNA, it helps in preventing carcinogenesis and atherogenesis. It is the most effective biological antioxidant agent which is also used in treatment of OSMF.[28], [29] Studies has reported statistically significant of lycopene supplement at a daily dose in improving patients with oral submucous fibrosis.[30]
Conclusion
OSMF is a chronic debilitating illness, of multifactorial etiology and no single traditional therapy has proven conclusive. Adjuvant medicine is expected to be used for longer periods of time, because they have fewer side effects. It is said to be safe and cost is also less hence it can be used along with traditional treatment of OSMF. Even literature supports the successful outcome of the adjuvant therapies in management of oral submucous fibrosis, but there is inadequate evidence for definitive form of treatment. Therefore, appropriate studies need to be reviewed to increase understanding of adjuvant therapy for treatment of OSMF.
Financial Support and Sponsorship
Nil.
Conflicts of Interest
There are no conflicts of interest.
References
- Jens J. Pindborg, Satyavati M. Sirsat. Oral submucous fibrosis. Oral Surg Oral Med, Oral Pathol 1966. [Google Scholar]
- W.M. Tilakaratne, M.F. Klinikowski, Takashi Saku, T.J. Peters, Saman Warnakulasuriya. Oral submucous fibrosis: Review on aetiology and pathogenesis. Oral Oncol 2006. [Google Scholar]
- Chandramani B. More, Sunanda Das, Hetul Patel, Chhaya Adalja, Vaishnavee Kamatchi, Rashmi Venkatesh. Proposed clinical classification for oral submucous fibrosis. Oral Oncol 2012. [Google Scholar]
- AR Kerr, S Warnakulasuriya, AJ Mighell, T Dietrich, M Nasser, J Rimal. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Diseases 2011. [Google Scholar]
- S. Warnakulasuriya, Newell. W. Johnson, I. Van Der Waal. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007. [Google Scholar]
- S R Aziz. Oral submucous fibrosis: an unusual disease. J N JDentAsooc 1997. [Google Scholar]
- J P Canniff, W Harvey, M Harris. Oral submucous fibrosis: its pathogenesis and management. Br Dent J 1986. [Google Scholar]
- J J Pindborg, F S Mehta, D K Daftary. Occurrence of Epithelial Atypia in 51 Indian Villagers with Oral Submucous Fibrosis. Br J Cancer 1970. [Google Scholar]
- T J Sambandan. Medical Treatment Modalities of Oral Sub Mucous Fibrosis. Natl J Integr Res Med 2011. [Google Scholar]
- A Srivastava, R Agarwal, O P Singh. Clinical evaluation of the role of tulsi and turmeric in the management of oral submucous fibrosis: A pilot, prospective observational study. J Ayurveda Integr Med 2015. [Google Scholar]
- Santosh K. Sandur, Haruyo Ichikawa, Manoj K. Pandey, Ajaikumar B. Kunnumakkara, Bokyung Sung, Gautam Sethi. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 2007. [Google Scholar]
- Prem Prakash, Ankita Misra, William R. Surin, Manish Jain, Rabi S. Bhatta, Raghvendra Pal. Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb Res 2011. [Google Scholar]
- P Suryanarayana, K Krishnaswamy, G B Reddy. Effect of curcumin on galactose-induced cataractogenesis in rats. Mol Vis 2003. [Google Scholar]
- Ramadasan Kuttan, P.C. Sudheeran, C.D. Josph. Turmeric and Curcumin as Topical Agents in Cancer Therapy. Tumori J 1987. [Google Scholar]
- N Agarwal. Evaluation of efficacy of turmeric in management of oral [21] submucous fibrosis. J Indian Acad Oral Med Radiol 2014. [Google Scholar]
- O P Sharma. Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 1976. [Google Scholar]
- A.J. Ruby, G. Kuttan, K. Dinesh Babu, K.N. Rajasekharan, R. Kuttan. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 1995. [Google Scholar]
- Ramachandran Sudarshan, Rajeshwari G. Annigeri, G. Sree Vijayabala. Aloe vera in the treatment for oral submucous fibrosis - a preliminary study. J Oral Pathol Med 2012. [Google Scholar]
- Nidhi Dwivedi, Akhil Agarwal. Aloe vera: Magic or myth. SRM J Res Dent Sci 2013. [Google Scholar]
- P Prakash, N Gupta. Therapeutic uses of Ocimum sanctum linn (Tulsi) with a note on eugenol and its pharmacological actions: A short review. Indian J Physiol Pharmacol 2005. [Google Scholar]
- M.A. Kelm, M.G. Nair, G.M. Strasburg, D.L. DeWitt. Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn.. Phytomed 2000. [Google Scholar]
- P Bhattacharyya, A Bishayee. Ocimum sanctum Linn. (Tulsi): an ethnomedicinal plant for the prevention and treatment of cancer. Anticancer Drugs 2013. [Google Scholar]
- Rahul Agarwal, T P Chaturvedi, Akhilesh Chandra, O P Singh, Adit Srivastava. Clinical evaluation of the role of tulsi and turmeric in the management of oral submucous fibrosis: A pilot, prospective observational study. J Ayurveda Integr Med 2015. [Google Scholar]
- M.S. Miranda, R.G. Cintra, S.B.M. Barros, J. Mancini-Filho. Antioxidant activity of the microalga Spirulina maxima. Braz J Med Biol Res 1998. [Google Scholar]
- Prathima Shetty, Prashanth Shenai, Laxmikanth Chatra, PrasannaKumar Rao. Efficacy of spirulina as an antioxidant adjuvant to corticosteroid injection in management of oral submucous fibrosis. Indian J Dent Res 2013. [Google Scholar]
- Revant H. Chole, Shailesh M. Gondivkar, Amol R. Gadbail, Swati Balsaraf, Sudesh Chaudhary, Snehal V. Dhore. Review of drug treatment of oral submucous fibrosis. Oral Oncol 2012. [Google Scholar]
- Babu Mathew, Rengaswamy Sankaranarayanan, Padmanabhan P. Nair, Cherian Varghese, Thara Somanathan, B. Padmavathy Amma. Evaluation of chemoprevention of oral cancer withspirulina fusiformis. Nutr Cancer 1995. [Google Scholar]
- R Lu, H Dan, R Wu, W Meng, N Liu, Jin X. Lycopene: Features and potential significance in the oral cancer and precancerous lesions. J Oral Pathol Med 2011. [Google Scholar]
- Nisheeth Saawarn, Swati Saawarn, Nallan CSK Chaitanya, M C Shashikanth, Vasanti Jirge, R Pinakapani. Lycopene in the management of oral lichen planus: A placebo-controlled study. Indian J Dent Res 2011. [Google Scholar]
- Abhinav Kumar, Anjana Bagewadi, Vaishali Keluskar, Mohitpal Singh. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007. [Google Scholar]
How to Cite This Article
Vancouver
Devi MS, J M, Rajpurohit R, Sophia K, Sorokhaibam B. Adjuvant therapy for oral submucous fibrosis [Internet]. Int J Oral Health Dent. 2020 [cited 2025 Sep 11];6(2):78-80. Available from: https://doi.org/10.18231/j.ijohd.2020.018
APA
Devi, M. S., J, M., Rajpurohit, R., Sophia, K., Sorokhaibam, B. (2020). Adjuvant therapy for oral submucous fibrosis. Int J Oral Health Dent, 6(2), 78-80. https://doi.org/10.18231/j.ijohd.2020.018
MLA
Devi, Mutum Sangeeta, J, Manju, Rajpurohit, Rahul, Sophia, Khumukcham, Sorokhaibam, Binita. "Adjuvant therapy for oral submucous fibrosis." Int J Oral Health Dent, vol. 6, no. 2, 2020, pp. 78-80. https://doi.org/10.18231/j.ijohd.2020.018
Chicago
Devi, M. S., J, M., Rajpurohit, R., Sophia, K., Sorokhaibam, B.. "Adjuvant therapy for oral submucous fibrosis." Int J Oral Health Dent 6, no. 2 (2020): 78-80. https://doi.org/10.18231/j.ijohd.2020.018